Consolidated Statements of Cash Flows (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net income	$ 202	$ 298
Less: Income (loss) from discontinued operations	(22)	12
Income from continuing operations	224	286
Adjustments to reconcile to net cash provided by operating activities:
Depreciation, decommissioning and amortization	410	414
Regulatory impacts of net nuclear decommissioning trust earnings	29	25
Impairment and other charges	231	0
Deferred income taxes and investment tax credits	(6)	174
Other	23	23
Changes in operating assets and liabilities:
Receivables	112	(38)
Inventory	(12)	(11)
Accounts payable	(63)	(65)
Other current assets and liabilities	(80)	(120)
Derivative assets and liabilities, net	(46)	79
Regulatory assets and liabilities, net	(331)	(199)
Other noncurrent assets and liabilities	7	(62)
Net cash provided by operating activities	498	506
Cash flows from financing activities:
Long-term debt issued, net of premium, discount, and issuance costs of $1 and $4 for the three months ended March 31, 2014 and 2013, respectively ($0 and $4 for SCE, respectively)	(1)	394
Long-term debt matured or repurchased	(2)	(1)
Preference stock issued, net	270	387
Preference stock redeemed	0	(400)
Short-term debt financing, net	401	245
Settlements of stock-based compensation, net	(42)	(32)
Dividends to noncontrolling interests	(30)	(30)
Dividends paid	(116)	(110)
Net cash provided by financing activities	480	453
Cash flows from investing activities:
Capital expenditures	(940)	(979)
Proceeds from sale of nuclear decommissioning trust investments	1,502	435
Purchases of nuclear decommissioning trust investments and other	(1,536)	(466)
Other	(1)	(4)
Net cash used by investing activities	(975)	(1,014)
Net (decrease) increase in cash and cash equivalents	3	(55)
Cash and cash equivalents at beginning of period	146	170
Cash and cash equivalents at end of period	149	115
Southern California Edison
Cash flows from operating activities:
Net income	234	283
Income from continuing operations	234	283
Adjustments to reconcile to net cash provided by operating activities:
Depreciation, decommissioning and amortization	410	414
Regulatory impacts of net nuclear decommissioning trust earnings	29	25
Impairment and other charges	231	0
Deferred income taxes and investment tax credits	(12)	150
Other	22	22
Changes in operating assets and liabilities:
Receivables	111	1
Inventory	(7)	(11)
Accounts payable	(55)	(63)
Other current assets and liabilities	(80)	(93)
Derivative assets and liabilities, net	(46)	79
Regulatory assets and liabilities, net	(331)	(199)
Other noncurrent assets and liabilities	15	(47)
Net cash provided by operating activities	521	561
Cash flows from financing activities:
Long-term debt issued, net of premium, discount, and issuance costs of $1 and $4 for the three months ended March 31, 2014 and 2013, respectively ($0 and $4 for SCE, respectively)	0	394
Long-term debt matured or repurchased	(2)	(1)
Preference stock issued, net	270	387
Preference stock redeemed	0	(400)
Short-term debt financing, net	229	229
Settlements of stock-based compensation, net	(22)	(29)
Dividends paid	(30)	(150)
Net cash provided by financing activities	445	430
Cash flows from investing activities:
Capital expenditures	(939)	(979)
Proceeds from sale of nuclear decommissioning trust investments	1,502	435
Purchases of nuclear decommissioning trust investments and other	(1,536)	(466)
Other	(1)	1
Net cash used by investing activities	(974)	(1,009)
Net (decrease) increase in cash and cash equivalents	(8)	(18)
Cash and cash equivalents at beginning of period	54	45
Cash and cash equivalents at end of period	$ 46	$ 27